Cytk investor relations
WebDec 14, 2024 · A "bruising" Food and Drug Administration meeting for Cytokinetics ( CYTK) was actually a blessing in disguise, an analyst said Wednesday as CYTK stock surged. Late Tuesday, a panel of FDA... WebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46...
Cytk investor relations
Did you know?
WebMar 1, 2024 · Cytokinetics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.96 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by... WebApr 4, 2024 · We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold …
WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Yahoo. 04/03 16:00. UBS Adjusts Cytokinetics Price Target to $61 From $67, Maintains Buy Rating. MT Newswires. 04/03 10:50. Cantor Fitzgerald Adjusts Price Target on Cytokinetics to $59 From $61, Maintains Overweight Rating. MT Newswires. WebApr 11, 2024 · A live audio webcast of the presentation will be available on the "News, Events, and Webcasts" tab via the Investor Relations section of the Company's website at https: ... Cytokinetics (CYTK ...
WebThe Investor Relations website contains information about Corteva Agriscience's business for stockholders, potential investors, and financial analysts. Investors Corteva Agriscience Skip to main navigation IR Home Company Corteva.com History Leadership Events & Presentations Financial Information Quarterly Earnings Reports
WebMar 15, 2024 · INVESTORS & MEDIA CALENDAR - UPCOMING EVENTS Webcast Barclays Global Healthcare Conference Mar 15, 2024 3:35 PM EDT Webcast Oppenheimer 33rd Annual Healthcare Conference Mar …
WebFeb 9, 2024 · As of February 8, 2024, the average one-year price target for Cytokinetics is $63.31. The forecasts range from a low of $47.47 to a high of $84.00. The average price target represents an increase... stat priority for windwalker monkWebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... stat priority frost dk pvpWebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in … Cytokinetics to Participate in Upcoming Investor Conferences. link: March 4, … ACC.23 Investor Event: REDWOOD-HCM Cohort 4 & FOREST-HCM 1.1 MB. Apr … Transfer Agent: Computershare 462 South 4th Street Louisville, KY 40202 Phone … Investor FAQ. IR/Media Contacts. Corporate Governance. Information … Investor FAQ. IR/Media Contacts. Corporate Governance. Information … Cytokinetics, Inc. is followed by the analysts listed above. Please note that any … stat priority havoc demon hunterWebApr 6, 2024 · Cytokinetics started at overweight with $58 stock price target at J.P. Morgan. Dec. 10, 2024 at 6:59 a.m. ET by Tomi Kilgore. Biotech and Pharma Cytokinetics Stock … stat priority frost mage dragonflightWebFeb 9, 2024 · The firm increased its portfolio allocation in CYTK by 43.66% over the last quarter. Polar Capital Holdings holds 2,672K shares representing 2.82% ownership of … stat priority havoc demon hunter pvpWebApr 7, 2024 · Annual Report to Security Holders (ars) April 07 2024 - 04:08PM Edgar (US Regulatory) This regulatory filing also includes additional resources: edge20006209x502_ars.pdf Cytokinetics... stat priority hexblade paladin dndWebApr 10, 2024 · More information regarding Humana is available to investors via the Investor Relations page of the company's web site at www.humana.com, including copies of: - Annual reports to stockholders ... stat priority holy paladin